info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Transplant diagnostics Companies

Transplant diagnostics companies play a critical role in the field of organ transplantation by providing diagnostic tests and solutions to ensure the compatibility and long-term success of organ and tissue transplants. These companies offer a range of products and services, including histocompatibility testing, organ matching, and monitoring for transplant recipients.

Transplant Diagnostics Key Companies


*Disclaimer: List of key companies in no particular order


Latest Transplant diagnostics Companies Update



  • April 2023: Quest Diagnostics DGX announced the launch of Quest Advanced Specialized Transplant Services in April 2023. The portfolio includes over 170 specialized tests for transplants and infectious diseases, longitudinal trend analysis of test results in the physician's electronic medical record (EMR), and continual medical consultation to guarantee optimal test selection and findings interpretation that impact therapy. The early services that Quest Diagnostics provided in the field of transplant testing have been complemented by the company's full portfolio of advanced diagnostics and support services.



  • July 2023: Verici Dx, a firm that specializes in diagnostics based on RNA signatures and artificial intelligence technologies for kidney transplants, will begin selling its goods to the general public in July 2023. These not only enhance acceptance rates and expand the lifespan of organs, but they also make substantial strides in the improvement of treatment regimens and bring down the cost of medical care. The effectiveness of the platform has been demonstrated, and these two trials have the potential to pave the way for comparable scientific advances with regard to other subjects. To get started, you might want to take some Protega, which is a drug that was created to predict the risk of fibrosis and long-term graft failure.



  • October 2022: A reference laboratory was established by Plexision, a US-based biotechnology company, in Hyderabad, India, in October 2022. At this facility, patients waiting for transplants will have access to the complete range of diagnostic services that are available. Just a few examples include drug monitoring, pharmacogenomics, genetic testing, and the organization's very own diagnostics for determining the likelihood of rejection and viral infections in transplant patients. At the annual conference of the Indian Society for Organ Transplantation, which took place this week in Nagpur, India, the business presented its new products for the first time.


List of Transplant diagnostics Key companies in the market

  • Becton Dickinson and Company (U.S.)

  • Bio-Rad Laboratories Inc (U.S.)

  • Illumina Inc (U.S.)

  • Immucor Transplant Diagnostics Inc (U.S.)

  • Thermo Fisher Scientific Inc (U.S.)

  • CareDx (U.S.)

  • Affymetrix Inc (U.S.)

  • Linkage Biosciences (U.S.)

  • Abbott Laboratories Inc (U.S.)

  • BioMérieux S.A. (France)

  • QIAGEN NV (Netherlands)


 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.